Aledade's editorial in response to the editor in chief’s December 2021 letter which discusses evidence supporting the cost-effectiveness of an innovative advance care planning initiative.
This document provides helpful talking points when speaking to patients about the CACP program, and highlights talking to patients who already have advance directives about the additional value of CACP.